Vaccines contain antigens that are weakened versions of viruses or
something that looks like a virus. These produce antibodies that
protect the body if exposed to the same antigens in the future. Since
2000, the global vaccine market has almost tripled, making the
vaccine industry one of the fastest growing sectors in the
pharmaceutical industry. The sales of new and costly vaccines are
higher in developed countries which account for more than half of the
total vaccine sales globally. Broadly, the vaccines market is
categorized into pediatric vaccines and adult vaccines. The pediatric
vaccines segment accounts for a significant market share of 57.6% of
the total vaccines market.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28370
Unmet needs for vaccination, especially in developing countries,
large funding from national governments and international bodies such
as the World Health Organization (WHO) and philanthropy
organizations such as Bill & Melinda Gates Foundation, research
and development of new vaccines, increasing awareness, development of
low-cost vaccine manufacturing facilities, entry of China market are
factors driving the growth of the vaccine market. Additionally, the
vaccine supply is generally looked through state government funding
under public health support. This has reduced the barrier to
immunization by providing free vaccines to infants and children in
need. Governments across the world are striving to ensure that every
part of a country should get easy access to immunization irrespective
of its social and economic status. This resulted in the launch of
Global Vaccine Action Plan (GVAP) in May 2012 by the WHO that was
authorized by 194 member states of the World Health Assembly. The
UNICEF and the WHO have published certain guidelines to develop a
national immunization plan and a comprehensive multi-year plan (cMYP)
for all the countries aiming for an easy access to vaccination
facilities for all individuals.
Furthermore, increasing research and development activities by
pharmaceutical companies are driving the growth of the vaccines
market. Needle-free vaccines, edible vaccines, intranasal vaccines,
and vaccine patches and chips are expected to enter the market soon.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=28370
The children vaccination market is segmented on the basis of type of
vaccine, severity and prevalence of disease, indication, end-user,
and region. In terms of type of vaccine, the market is categorized as
attenuated live viruses, inactivated (killed) viruses, subunit
vaccines including purified or recombinant viral antigen, recombinant
virus vaccines, anti-idiotype antibodies, and DNA vaccines. In terms
of severity of disease, the market is segmented as Universal
Immunization Program (UIP++) vaccines, mandatory vaccines, regular
optional vaccines, one-time optional vaccines (exhibit), and post
incident vaccines. The UIP segment, vaccines for diseases with a high
life-threatening potential and particularly recommended for infants,
includes bacillus Calmette-Guerin (BCG) vaccine and diphtheria,
pertussis and tetanus (DPT) vaccine.
Few of the emerging vaccines which are soon to be included in UIP and
considered as mandatory are pneumococcal; meningococcal; measles,
mumps, and rubella (MMR); human papilloma virus (HPV); and rotavirus.
Vaccines for diseases with a low life-threatening potential
(generally for adults) include typhoid and one-time optional vaccines
such as cholera. Post incident vaccines include rabies vaccine. Based
on indication, the market is segmented as DTP, pneumococcal disease,
meningococcal disease, influenza, hepatitis, varicella, polio, MMR,
human papilloma virus (HPV) infection, and others. In terms of
end-user, the market is segmented as pediatrics and adults. The
pediatrics segment is expected to grow faster as a result of
increasing prevalence of diseases in children.
Geographically, the market is distributed over North America, Latin
America, Europe, Asia Pacific, and Middle East & Africa. North
America dominates the global market for children vaccination owing to
the increasing government support and growing research and
development by numerous companies. Europe is the second largest
market after North America. The market in Asia Pacific is projected
to expand at a fast growth rate owing to high birth rate in India and
China.
The global children vaccination market is dominated by key players
such as GlaxoSmithKline, Sanofi Pasteur, Merck & Co., Pfizer, and
Novartis.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment